METTL13 and urinary bladder carcinoma: Using a western blot analysis, we confirmed that low levels of METTL13 mRNA resulted in the downregulation of METTL13 protein in 55 randomly selected bladder cancer samples compared with corresponding normal bladder tissue (Fig. 1H).